Alembic Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 05, 2025
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has announced its 15th AGM on Tuesday, August 5, 2025 at 3:00 p.m. via video conferencing. Shareholders will consider adopting the FY25 audited financial statements and declaring a dividend for FY 2024-25 (record date: July 29, 2025; payment from August 7, 2025). Key proposals include appointing M/s. KKC & Associates LLP as new statutory auditors for 5 years (FY26–FY30), replacing K.C. Mehta & Co. LLP, with an audit fee of ₹60 lakhs plus taxes per year. Mr. Chirayu Amin will be re-designated as Executive Chairman (from CEO) for 5 years from April 1, 2026, with a maximum CTC of ₹12 crore per annum plus up to 1% commission on net profits. Mr. Pranav Amin will be re-appointed as Managing Director for another 5-year term. Approval is also sought for paying commission to non-executive directors (up to 0.50% of net profits for FY27–FY31) and appointing Samdani Shah & Kabra as secretarial auditors.
This is a routine AGM notice, not an unexpected event. The dividend declaration and key board appointments are positive for shareholder continuity. The change in statutory auditors is procedural as the previous firm's 5-year term ends. Remote e-voting opens August 2 and ends August 4, 2025.